These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 18052043)

  • 1. Structural analysis of immunotherapeutic peptides for autoimmune Myasthenia gravis.
    Jung HH; Yi HJ; Lee SK; Lee JY; Jung HJ; Yang ST; Eu YJ; Im SH; Kim JI
    Biochemistry; 2007 Dec; 46(51):14987-95. PubMed ID: 18052043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural characterization of the main immunogenic region of the Torpedo acetylcholine receptor.
    Morell SW; Trinh VB; Gudipati E; Friend A; Page NA; Agius MA; Richman DP; Fairclough RH
    Mol Immunol; 2014 Mar; 58(1):116-31. PubMed ID: 24333757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational requirements for molecular recognition of acetylcholine receptor main immunogenic region (MIR) analogues by monoclonal anti-MIR antibody: a two-dimensional nuclear magnetic resonance and molecular dynamics approach.
    Tsikaris V; Detsikas E; Sakarellos-Daitsiotis M; Sakarellos C; Vatzaki E; Tzartos SJ; Marraud M; Cung MT
    Biopolymers; 1993 Jul; 33(7):1123-34. PubMed ID: 8343589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and conformational study of biologically active photolabeled analogues of the main immunogenic region of the acetylcholine receptor.
    Theodorou V; Tsikaris V; Sakarellos-Daitsiotis M; Avramopoulou V; Kostelidou K; Tzartos SJ; Sakarellos C
    Biopolymers; 2000-2001; 56(1):37-46. PubMed ID: 11582576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular modeling of the complex between Torpedo acetylcholine receptor and anti-MIR Fab198.
    Konstantakaki M; Tzartos SJ; Poulas K; Eliopoulos E
    Biochem Biophys Res Commun; 2007 May; 356(3):569-75. PubMed ID: 17376405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myasthenia gravis studied by monoclonal antibodies to the acetylcholine receptor.
    Tzartos SJ
    In Vivo; 1988; 2(1):105-10. PubMed ID: 2979808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of passively transferred experimental autoimmune myasthenia gravis by a phage library-derived cyclic peptide.
    Venkatesh N; Im SH; Balass M; Fuchs S; Katchalski-Katzir E
    Proc Natl Acad Sci U S A; 2000 Jan; 97(2):761-6. PubMed ID: 10639153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The main immunogenic region of the nicotinic acetylcholine receptor. Identification of amino acid residues interacting with different antibodies.
    Bellone M; Tang F; Milius R; Conti-Tronconi BM
    J Immunol; 1989 Dec; 143(11):3568-79. PubMed ID: 2584708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of human anti-acetylcholine receptor monoclonal autoantibodies from the peripheral blood of a myasthenia gravis patient using combinatorial libraries.
    Rey E; Zeidel M; Rhine C; Tami J; Krolick K; Fischbach M; Sanz I
    Clin Immunol; 2000 Sep; 96(3):269-79. PubMed ID: 10964546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compared structures of the free nicotinic acetylcholine receptor main immunogenic region (MIR) decapeptide and the antibody-bound [A76]MIR analogue: a molecular dynamics simulation from two-dimensional NMR data.
    Orlewski P; Marraud M; Cung MT; Tsikaris V; Sakarellos-Daitsiotis M; Sakarellos C; Vatzaki E; Tzartos SJ
    Biopolymers; 1996; 40(5):419-32. PubMed ID: 9062066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The third-dimensional structure of the complex between an Fv antibody fragment and an analogue of the main immunogenic region of the acetylcholine receptor: a combined two-dimensional NMR, homology, and molecular modeling approach.
    Kleinjung J; Petit MC; Orlewski P; Mamalaki A; Tzartos SJ; Tsikaris V; Sakarellos-Daitsiotis M; Sakarellos C; Marraud M; Cung MT
    Biopolymers; 2000 Feb; 53(2):113-28. PubMed ID: 10679615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myasthenia gravis: effect on antibody binding of conservative substitutions of amino acid residues forming the main immunogenic region of the nicotinic acetylcholine receptor.
    Wahlsten JL; Lindstrom JM; Ostlie N; Wu XD; Conti-Tronconi BM
    J Recept Res; 1993; 13(5):863-79. PubMed ID: 8463998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of RNA aptamer activity against myasthenic autoantibodies by extended sequence selection.
    Hwang B; Lee SW
    Biochem Biophys Res Commun; 2002 Jan; 290(2):656-62. PubMed ID: 11785949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An FcgammaRIIa-binding peptide that mimics the interaction between FcgammaRIIa and IgG.
    Cendron AC; Wines BD; Brownlee RT; Ramsland PA; Pietersz GA; Hogarth PM
    Mol Immunol; 2008 Jan; 45(2):307-19. PubMed ID: 17673295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of peripheral B cells and autoantibodies against the anti-nicotinic acetylcholine receptor derived from patients with myasthenia gravis using single-cell manipulation tools.
    Makino T; Nakamura R; Terakawa M; Muneoka S; Nagahira K; Nagane Y; Yamate J; Motomura M; Utsugisawa K
    PLoS One; 2017; 12(10):e0185976. PubMed ID: 29040265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic lactam analogues containing the main immunogenic region of Torpedo acetylcholine receptor.
    Detsikas E; Tsikaris V; Sakarellos-Daitsiotis M; Sakarellos C; Cung MT; Marraud M; Vatzaki E; Tzartos SJ
    Pept Res; 1993; 6(1):17-23. PubMed ID: 7679937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of auto-antibodies against nAChR in myasthenic serum and their pathogenic roles in experimental autoimmune myasthenia gravis.
    Nakamura R; Makino T; Hanada T; Terakawa M; Nagahira K; Yamate J; Shiraishi H; Motomura M
    J Neuroimmunol; 2018 Jul; 320():64-75. PubMed ID: 29759142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesangial proliferative glomerulonephritis with deposits of anti-nicotinic acetylcholine receptor antibody in a patient with myasthenia gravis.
    Mitsui T; Okada K; Kuhara T; Hashizume T; Okazaki S; Kawajiri M; Matsumoto T
    J Clin Neurosci; 2001 Sep; 8(5):454-6. PubMed ID: 11535018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of epitopes recognized by the antibodies to alpha(181-192) peptides of neuronal nicotinic acetylcholine receptors: extrapolation to the structure of acetylcholine-binding domain.
    Skok M; Lykhmus E; Bobrovnik S; Tzartos S; Tsouloufis T; Vanderesse R; Coutrot F; Thong Cung M; Marraud M; Krikorian D; Sakarellos-Daitsiotis M
    J Neuroimmunol; 2001 Dec; 121(1-2):59-66. PubMed ID: 11730940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural mimicry of O-antigen by a peptide revealed in a complex with an antibody raised against Shigella flexneri serotype 2a.
    Theillet FX; Saul FA; Vulliez-Le Normand B; Hoos S; Felici F; Weintraub A; Mulard LA; Phalipon A; Delepierre M; Bentley GA
    J Mol Biol; 2009 May; 388(4):839-50. PubMed ID: 19328810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.